Author/Authors :
Moossavi، Shirin نويسنده , , Bishehsari، Faraz نويسنده , , Ansari، Reza نويسنده , , Vahedi، Homayoon نويسنده , , Nasseri-Moghaddam، Siavosh نويسنده , , Merat، Shahin نويسنده , , Sobhani، Iradj نويسنده , , Keshavarzian، Ali نويسنده , , Malekzadeh، Reza نويسنده ,
Abstract :
Fecal microbiota transplant (FMT) research trials are growing in diverse intestinal and extraintestinal conditions that are thought to be either caused or correlated with gut microbiota dysbiosis. Although, the mechanism by which the microbiota results in disease initiation or progression is not fully understood, it is speculated that restoring the symbiosis by FMT could have therapeutic benefits.
